Medly AI Raises £6M Seed Funding for Exam Prep Platform

An innovative artificial intelligence platform designed to revolutionize exam preparation has successfully closed a £6 million seed funding round. Medly AI, which positions itself as the first AI tutor specifically for academic assessments, will leverage this capital to enhance its adaptive learning technology and broaden its reach within the education sector.

The London-based edtech firm, founded by former UCL medical graduates Dr. Paul Jung and Dr. Kavi Samra, has rapidly gained traction since its launch in early 2025. Medly AI reports an impressive user base exceeding 400,000 students across the United Kingdom. The platform's core functionality lies in its sophisticated AI, built upon advanced large language models, which provides personalized tutoring experiences. It dynamically adjusts to individual learning styles, monitors student progress, and offers tailored support, aiming to democratize access to high-quality academic assistance.

Early results from Medly AI's platform are compelling. During the last GCSE exam period, the company states that 74% of students utilizing the service achieved at least a one-grade improvement in their results. This significant uplift underscores the potential of AI to bridge the educational equity gap, offering students from all socioeconomic backgrounds a powerful tool previously accessible primarily through expensive private tutoring.

The substantial seed investment was spearheaded by prominent venture capital firm Felix Capital. The round also saw continued support from existing investors, including Eka Ventures and Ada Ventures, alongside contributions from several angel investors. This strong backing from both new and returning stakeholders highlights confidence in Medly AI's vision and its demonstrated impact on student outcomes.

Dr. Paul Jung, who serves as Medly AI's Chief Executive Officer, emphasized the platform's mission: "Our bespoke AI provides every student with a 24/7 personal tutor that evolves with their learning pace and addresses their specific requirements. Seeing the majority of our users improve by a full grade in a single exam cycle is transformative for young learners." This sentiment was echoed by Angela Chou of Felix Capital, who noted, "We are particularly drawn to Medly's mission and proven ability to deliver effective, AI-driven exam preparation to hundreds of thousands of young people." Chou also praised the founders' personal journeys and their rapid scaling of the platform.

Medly AI's recent funding success follows its selection for the Department for Education's AI Tutoring Tools Pioneers Programme. This recognition places Medly AI alongside established players like Pearson and ElevenLabs, underscoring its role in developing innovative tools aimed at improving academic attainment, particularly for disadvantaged students throughout England. The broader edtech market continues to see significant investment, driven by the increasing demand for personalized and accessible learning solutions, with AI playing a pivotal role in shaping the future of education.